Details

Autor(en) / Beteiligte

• Schepetkin, Igor A
• Karpenko, Oleksander S
• Kovrizhina, Anastasia R
• Kirpotina, Liliya N
• Khlebnikov, Andrei I
• Chekal, Stepan I
• Radudik, Alevtyna V
• Shybinska, Maryna O
• Quinn, Mark T

Titel

Novel Tryptanthrin Derivatives with Selectivity as c -Jun N-Terminal Kinase (JNK) 3 Inhibitors

Ist Teil von

• Molecules (Basel, Switzerland), 2023-06, Vol.28 (12), p.4806

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2023

Link zum Volltext

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• The -Jun N-terminal kinase (JNK) family includes three proteins (JNK1-3) that regulate many physiological processes, including cell proliferation and differentiation, cell survival, and inflammation. Because of emerging data suggesting that JNK3 may play an important role in neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease, as well as cancer pathogenesis, we sought to identify JNK inhibitors with increased selectivity for JNK3. A panel of 26 novel tryptanthrin-6-oxime analogs was synthesized and evaluated for JNK1-3 binding (K ) and inhibition of cellular inflammatory responses. Compounds (8-methoxyindolo[2,1- ]quinazolin-6,12-dione oxime) and (8-phenylindolo[2,1- ]quinazolin-6,12-dione oxime) had high selectivity for JNK3 versus JNK1 and JNK2 and inhibited lipopolysaccharide (LPS)-induced nuclear factor-κB/activating protein 1 (NF-κB/AP-1) transcriptional activity in THP-1Blue cells and interleukin-6 (IL-6) production by MonoMac-6 monocytic cells in the low micromolar range. Likewise, compounds , , and pan-JNK inhibitor (9-methylindolo[2,1- ]quinazolin-6,12-dione oxime) decreased LPS-induced -Jun phosphorylation in MonoMac-6 cells, directly confirming JNK inhibition. Molecular modeling suggested modes of binding interaction of these compounds in the JNK3 catalytic site that were in agreement with the experimental data on JNK3 binding. Our results demonstrate the potential for developing anti-inflammatory drugs based on these nitrogen-containing heterocyclic systems with selectivity for JNK3.